UTHR - United Therapeutics Inc. Revenue Dynamics YoY (Last Twelve Months)

Graphic logo of United Therapeutics Inc. (UTHR)

United Therapeutics (UTHR) manufacturing facilities in the US ensure the production of unique drugs for rare pathologies. The annual change in sales volume over the LTM demonstrates revenue dynamics, where the current parameter equals 2.00. Growth is driven by leadership in pulmonary hypertension therapy and xenotransplantation, although business resilience depends on patent protection and success in transplantology.

UTHR United Therapeutics Corp: Sales Growth YoY (Last Twelve Months) in the range 02/11/2024 - 11/18/2026

unither.com (UTHR) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Fundamental company valuation:UTHR (United Therapeutics Inc.)
Mass-produced product of United Therapeutics

To identify fundamentally resilient assets, investors must distinguish market noise from actual revenue dynamics. The TTM annual revenue growth metric measures the percentage change in total sales over the last 12 months, allowing for an assessment of the business expansion rates of United Therapeutics (UTHR) amid risks of losing exclusivity for key drugs and pressure from generics.

Competitors of United Therapeutics (UTHR)